Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care.